Peregrine Capital Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.3M | Buy |
164,341
+2,935
| +2% | +$219K | 0.37% | 57 |
|
|
2025
Q1 | $10.3M | Buy |
161,406
+19,603
| +14% | +$1.25M | 0.34% | 63 |
|
|
2024
Q4 | $11.1M | Buy |
141,803
+2,400
| +2% | +$187K | 0.33% | 65 |
|
|
2024
Q3 | $11.2M | Buy |
139,403
+13,262
| +11% | +$1.07M | 0.34% | 60 |
|
|
2024
Q2 | $10.4M | Sell |
126,141
-8,462
| -6% | -$700K | 0.3% | 70 |
|
|
2024
Q1 | $11.5M | Buy |
134,603
+24,290
| +22% | +$2.07M | 0.33% | 63 |
|
|
2023
Q4 | $9.43M | Sell |
110,313
-18,094
| -14% | -$1.55M | 0.28% | 84 |
|
|
2023
Q3 | $11.5M | Sell |
128,407
-7,415
| -5% | -$664K | 0.34% | 72 |
|
|
2023
Q2 | $11.6M | Sell |
135,822
-14,923
| -10% | -$1.27M | 0.31% | 94 |
|
|
2023
Q1 | $12.5M | Buy |
150,745
+17,406
| +13% | +$1.44M | 0.36% | 75 |
|
|
2022
Q4 | $10.5M | Sell |
133,339
-16,991
| -11% | -$1.34M | 0.33% | 110 |
|
|
2022
Q3 | $11.1M | Sell |
150,330
-27,055
| -15% | -$2M | 0.36% | 84 |
|
|
2022
Q2 | $11.6M | Sell |
177,385
-155
| -0.1% | -$10.1K | 0.35% | 95 |
|
|
2022
Q1 | $11.2M | Sell |
177,540
-13,135
| -7% | -$830K | 0.27% | 153 |
|
|
2021
Q4 | $10.1M | Buy |
190,675
+5,507
| +3% | +$292K | 0.2% | 198 |
|
|
2021
Q3 | $13.1M | Sell |
185,168
-23,398
| -11% | -$1.65M | 0.27% | 140 |
|
|
2021
Q2 | $13.9M | Buy |
+208,566
| New | +$13.9M | 0.25% | 184 |
|